Targeting OCT3 attenuates doxorubicin-induced cardiac injury

Authors: Huang, Kevin M., Thomas, Megan Zavorka, Magdy, Tarek, Eisenmann, Eric D., Uddin, Muhammad Erfan, DiGiacomo, Duncan F., Pan, Alexander, Keiser, Markus, Otter, Marcus, Xia, Sherry H., Li, Yang, Jin, Yan, Fu, Qiang, Gibson, Alice A., Bonilla, Ingrid M., Carnes, Cynthia A., Corps, Kara N., Coppola, Vincenzo, Smith, Sakima A., Addison, Daniel, Nies, Anne T., Bundschuh, Ralf, Chen, Taosheng, Lustberg, Maryam B., Wang, Joanne, Oswald, Stefan, Campbell, Moray J., Yan, Pearlly S., Baker, Sharyn D., Hu, Shuiying, Burridge, Paul W., Sparreboom, Alex

Source: Proceedings of the National Academy of Sciences of the United States of America, 2021 Feb 01. 118(5), 1-9.

Access URL: https://www.jstor.org/stable/27006166

Effects of frequently used pharmaceutical excipients on the organic cation transporters 1–3 and peptide transporters 1/2 stably expressed in MDCKII cells

Authors: Otter, Marcus, Oswald, Stefan, Siegmund, Werner, Keiser, Markus

Source: In European Journal of Pharmaceutics and Biopharmaceutics March 2017 112:187-195

Expression and Functional Contribution of Different Organic Cation Transporters to the Cellular Uptake of Doxorubicin into Human Breast Cancer and Cardiac Tissue.

Authors: Otter, Marcus¹ (AUTHOR) marcus.otter@yahoo.de, Csader, Susanne¹ (AUTHOR) susanne.csader@uef.fi, Keiser, Markus¹ (AUTHOR) markus.keiser@web.de, Oswald, Stefan² (AUTHOR) stefan.oswald@med.uni-rostock.de

Source: International Journal of Molecular Sciences. Jan2022, Vol. 23 Issue 1, p255. 1p.

Subject Terms: *ORGANIC cation transporters, *DOXORUBICIN, *BREAST cancer, *BRONCHIAL carcinoma, *CARRIER proteins, *MYOCARDIUM

Cellular uptake transport mechanisms of doxorubicin and their potential contribution to drug efficacy and safety

Authors: Keiser, Markus, Otter, Marcus, Csader, Susanne, Bien-Moeller, Sandra, Oswald, Stefan

Source: In Drug Metabolism and Pharmacokinetics January 2018 33(1) Supplement:S91-S91